Show simple item record

dc.contributor.authorEstella García, Ángel 
dc.contributor.authorCantón, María Luisa
dc.contributor.authorMuñoz, Laura
dc.contributor.authorRodriguez Higueras, Isabel
dc.contributor.authorRecuerda Núñez, María
dc.contributor.authorTejero Aranguren, Julia
dc.contributor.authorZaya, Benito
dc.contributor.authorGómez, Carmen
dc.contributor.authorAmaya, Roario
dc.contributor.authorHurtado Martinez, Ángela
dc.contributor.authorOdero Bernal, María del Valle
dc.contributor.authorDe la Fuente, Carmen
dc.contributor.authorAlados Arboledas, Juan Carlos
dc.contributor.authorGarnacho-Montero, José
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2022-09-12T11:59:56Z
dc.date.available2022-09-12T11:59:56Z
dc.date.issued2021-11
dc.identifier.issn2075-4426
dc.identifier.urihttp://hdl.handle.net/10498/27309
dc.description.abstractBackground: The aim of this study was to analyze the percentage of patients admitted to the ICU having received the vaccine against COVID-19, to describe the clinical profile of vaccinated patients admitted to the ICU, and to assess the humoral immune response to vaccination. Methods: In this multicenter prospective descriptive cohort study, consecutive critically ill patients with confirmed SARS-CoV-2 pneumonia who received at least one dose of the SARS-CoV-2 vaccine were included. The time of study was from 1 July to 10 August of 2021. Results: Of the 94 consecutive patients from seven Andalusian ICUs admitted during the time of study, 50 (53.2%) received at least one dose of anti SARS-CoV-2 vaccine. No patient was admitted having previously had SARS-CoV-2 infection. The B.1.617.2 (Delta) variant was the most frequently identified, in 80.76% of cases. Patients with a complete vaccination with non-optimal antibody levels were immunocompromised. Fifteen patients were admitted to the ICU with Acute Respiratory Distress Syndrome (ARDS) without having completed their vaccination; the clinical profile was younger and with less comorbidities compared to patients with full vaccination. There were no differences in severity of ARDS. Conclusions: Most of the patients who were admitted to the ICU having received a dose of the vaccine were not optimally vaccinated; fully vaccinated patients who did not obtain optimal serum antibody levels were patients considered immunocompromisedes_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Personalized Medicine, Vol. 11, Núm. 11es_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectsevere pneumoniaes_ES
dc.subjectacute respiratory distress syndromees_ES
dc.subjectvaccinees_ES
dc.subjectICUes_ES
dc.subjectDelta variant SARS-CoV-2es_ES
dc.titleVaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Studyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jpm11111086


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional